Cancer Research Cell Death Mechanisms and Cancer Therapy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ke, N.
Right arrow Articles by Li, Q.-X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ke, N.
Right arrow Articles by Li, Q.-X.
[Cancer Research 64, 8208-8212, November 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Nuclear Hormone Receptor NR4A2 Is Involved in Cell Transformation and Apoptosis

Ning Ke1, Gisela Claassen1, De-Hua Yu1, Aaron Albers1, Wufang Fan1, Philip Tan1, Mirta Grifman1, Xiuyuan Hu1, Kristin DeFife1, Vivian Nguy1, Bernd Meyhack2, Arndt Brachat2, Flossie Wong-Staal1 and Qi-Xiang Li1

1 Immusol, Inc., San Diego, California; and 2 Novartis Institutes for BioMedical Research, Basel, Switzerland

HeLaHF cells are transformation revertants of cervical cancer HeLa cells and have lost anchorage-independent growth potential and tumorigenicity. Activation of tumor suppressor(s) was implicated previously in this transformation reversion. In this study, expression profiling analysis was carried out to identify potential oncogenes that are down-regulated in HeLaHF cells. We found that all three members of the NR4A1/Nur77/NGFIB orphan nuclear hormone receptor subfamily (NR4A1, NR4A2, and NR4A3) were down-regulated in the HeLaHF revertant. Small interfering RNA-mediated down-regulation of NR4A2 in HeLa cells, either transiently or stably, resulted in reduced anchorage-independent growth that was largely attributable to increased anoikis. Furthermore, down-regulation of NR4A2 as well as NR4A1 promoted intrinsic apoptosis. These phenotypes were also observed in several other experimental cancer cells, suggesting the observed apoptosis suppression is a more general property of NR4A2 and NR4A1. These phenotypes also suggest that the Nur77/NGFIB subfamily of orphan receptors exhibit certain oncogenic functionalities with regards to cell proliferation and apoptosis and could therefore be evaluated as potential cancer therapeutic targets.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
X. Li and H.-H. Tai
Activation of thromboxane A2 receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells
Carcinogenesis, September 1, 2009; 30(9): 1606 - 1613.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
T. Zhang, P. Wang, H. Ren, J. Fan, and G. Wang
NGFI-B Nuclear Orphan Receptor Nurr1 Interacts with p53 and Suppresses Its Transcriptional Activity
Mol. Cancer Res., August 1, 2009; 7(8): 1408 - 1415.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-G. Kim, K. W. Lee, Y.-Y. Cho, N. J. Kang, S.-M. Oh, A. M. Bode, and Z. Dong
Mitogen- and Stress-Activated Kinase 1-Mediated Histone H3 Phosphorylation Is Crucial for Cell Transformation
Cancer Res., April 1, 2008; 68(7): 2538 - 2547.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. Ke, R. Sundaram, G. Liu, J. Chionis, W. Fan, C. Rogers, T. Awad, M. Grifman, D. Yu, F. Wong-Staal, et al.
Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway
Mol. Cancer Ther., June 1, 2007; 6(6): 1840 - 1850.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. S. Mix, M. G. Attur, H. Al-Mussawir, S. B. Abramson, C. E. Brinckerhoff, and E. P. Murphy
Transcriptional Repression of Matrix Metalloproteinase Gene Expression by the Orphan Nuclear Receptor NURR1 in Cartilage
J. Biol. Chem., March 30, 2007; 282(13): 9492 - 9504.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Kannan-Thulasiraman, E. Katsoulidis, M. S. Tallman, J. S. C. Arthur, and L. C. Platanias
Activation of the Mitogen- and Stress-activated Kinase 1 by Arsenic Trioxide
J. Biol. Chem., August 11, 2006; 281(32): 22446 - 22452.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. R. Holla, J. R. Mann, Q. Shi, and R. N. DuBois
Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer
J. Biol. Chem., February 3, 2006; 281(5): 2676 - 2682.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. C. Borczuk, H. K. Kim, H. A. Yegen, R. A. Friedman, and C. A. Powell
Lung Adenocarcinoma Global Profiling Identifies Type II Transforming Growth Factor-{beta} Receptor as a Repressor of Invasiveness
Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 729 - 737.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.